Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells

Mol Cancer Ther. 2002 Oct;1(12):1043-9.

Abstract

Recent studies suggest that several proteins can transverse biological membranes through protein transduction. The protein transduction domains of these proteins, 10-16 residues long, have been identified as critical domains for the protein transduction. Poly-arginine peptide also has the ability of protein transduction. Here, we show that the protein delivery system using 11 poly-arginine peptides (11R) is a powerful tool for the transduction of the biologically active tumor suppressor protein, p53, to suppress the proliferation of oral cancer cells. The 11R-fused p53 proteins (11R-p53) effectively penetrated across the plasma membrane of the cancer cells and translocated into the nucleus. The proteins induced the activity of the p21/WAF promoter and inhibited the proliferation of human oral cancer cells, in which the p53 gene was mutated. The effect was equivalent to that of the adenovirus-mediated p53 gene transduction system. Moreover, 11R-p53 enhanced the cisplatin-dependent induction of apoptosis of the cells. These data suggest that this protein transduction method may become a promising cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Adenoviridae / genetics
  • Antineoplastic Agents / pharmacology
  • Apoptosis
  • Blotting, Western
  • Cell Division
  • Cell Membrane / metabolism
  • Cell Nucleus / metabolism
  • Cell Survival
  • Cisplatin / pharmacology
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / metabolism
  • Gene Transfer Techniques*
  • Genes, Reporter
  • Genetic Vectors
  • Humans
  • Immunohistochemistry
  • Microscopy, Fluorescence
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / metabolism
  • Mouth Neoplasms / therapy*
  • Peptides / chemistry
  • Plasmids / metabolism
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins / metabolism
  • Time Factors
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Antineoplastic Agents
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Peptides
  • Recombinant Fusion Proteins
  • Tumor Suppressor Protein p53
  • polyarginine
  • Cisplatin